Translating botanical resources into verified clinical assets via precision green metrics, non-toxic processing, and closed-loop contract manufacturing.
OEM Animal study Supplier, Suppliers
Explore Service
China Screening of the active ingredient(s) of plants Manufacturer, Manufacturers
Explore Service
ODM Study and evaluation of the potency of the botanical active ingredient(s) from different seasons and different origins. Manufacturer, Suppliers
Explore Service
OEM In Vitro Test /Research Service Manufacturers, Suppliers
Explore Service
China Establishment of analysis methods of active ingredient(s) Supplier, Suppliers
Explore Service
ODM Clinic study (Phase1 - Phase 4） Manufacturer, Suppliers
Explore Service
Botanical Active Screening & Formulation Design Services
Explore Service
Standardized Green Analytical Method Establishment
Explore ServiceGlobal biopharmaceutical and consumer health enterprises face mounting pressure under Scope 1-3 regulatory mandates, Corporate Sustainability Due Diligence (CSDDD), and FDA/EMA botanical validation criteria.
International pharma conglomerates are moving beyond traditional price-per-kilogram sourcing. Demands now encompass complete life-cycle analyses (LCA), non-toxic solvent regimes (avoiding hazardous volatile organics), and verifiable provenance documentation aligned with EU green procurement taxonomies.
Depletion of wild resources and climatic variability necessitate multi-seasonal potency evaluations. Procurement leaders demand scientific guarantees that high-yield botanical batches maintain exact bioequivalent phenolic, polysaccharide, or alkaloid thresholds across cyclical harvests.
A classic bottleneck in green chemical sourcing is the "scale-up yield crash" where clean benchtop techniques fail at metric-ton batch scales. Green CDMO partners must offer vertically integrated pilot-to-bulk facilities managed directly by analytical and process chemists.
Operating across Changsha, Hunan, MedGence (Yineng Pharma) executes an industrial roadmap converting Traditional Chinese Medicine empirical data into quantifiable, ESG-compliant pharmaceutical actives.
Utilizing accumulated empirical databases across hundreds of thousands of research batches to isolate high-density bioactive candidate molecules without broad-acre ecological depletion.
Formulating high-performance liquid chromatography (HPLC), high-performance thin-layer chromatography (HPTLC), and gas chromatography (GC) assays minimizing toxic solvent consumption.
Engineering pilot-scale supercritical fluid extraction, membrane filtration, and continuous countercurrent green extraction pipelines ensuring thermal stability and ultra-low energy expenditure.
Delivering non-animal alternative in vitro testing suites followed by regulatory GLP animal safety (LD50, acute, chronic, genotoxicity) and Phase I–IV clinical validation dossiers for NDA/IND submissions.
Our sustained commitment to green chemical methodologies and reproducible science has earned the long-term trust of over 100 leading pharmaceutical enterprises and national medical institutions.
Long-term CDMO/CRO partner to national pharmaceutical groups including China Beijing Tongrentang Group, China Resources Sanjiu Medical & Pharmaceutical, Livzon Pharmaceutical Group, Humanwell Healthcare, and Sunflower Pharmaceutical Group.
Primary research partner supporting hospital preparation registrations (56 completed) for the Second Xiangya Hospital of Central South University, First and Second Hospitals of Hunan University of Chinese Medicine, and Shuguang Hospital affiliated with Shanghai University of TCM.
Every entrusted botanical campaign operates under airtight mutual non-disclosure frameworks. Process parameters, genetic markers, solvent ratios, and novel extract formulations remain the uncompromised intellectual property of the enterprise client.
Navigating complex international botanical compliance pathways with full dossier assistance, batch validation certificates, and global export packaging standards.
Active botanical pharmaceutical ingredients and dietary intermediates can be customized into diverse bulk physical states tailored for international shipping and formulation stability:
Fully certified pilot and commercial finished dosage manufacturing complying with stringent international cGMP and ISO guidelines:
Every batch shipped globally carries comprehensive documentation ensuring unhindered clearance by customs authorities and regional health regulators:
Clear answers for global sourcing directors, technical evaluators, and sustainability procurement leads.
Connect with our senior scientific team to commission targeted natural active screening, analytical protocol establishment, or pilot-to-commercial contract manufacturing.
OEM Animal study Supplier, Suppliers
Request Study Scope
China Screening of the active ingredient(s) of plants Manufacturer, Manufacturers
Request Study Scope
ODM Study and evaluation of the potency of the botanical active ingredient(s) from different seasons and different origins. Manufacturer, Suppliers
Request Study Scope
OEM In Vitro Test /Research Service Manufacturers, Suppliers
Request Study Scope
China Establishment of analysis methods of active ingredient(s) Supplier, Suppliers
Request Study Scope
ODM Clinic study (Phase1 - Phase 4） Manufacturer, Suppliers
Request Study Scope
In Vitro Testing for Cellular Efficacy and Mechanism Profiling
Request Study Scope
Origin and Seasonal Potency Evaluation for Raw Botanicals
Request Study Scope